E-LIB Suche - Ergebnisse für: Martinez-Sesmero, JM

1

HSD96 Burden of Patient Journey in the Management of Alpha-..:

Martínez-Sesmero, JM ; Cabeza, J ; Pablo, Q...
Value in Health. 25 (2022) 12 - p. S291 , 2022

2

Burden of diabetes mellitus in patients with acromegaly tre..:

Sánchez-Cenizo, L. ; Aller, J. ; Martínez-Sesmero, JM...
ClinicoEconomics and Outcomes Research. 11 (2019) - p. 465-475 , 2019

Link: https://doi.org/10.2147/..

3

Economic Evaluation of A Patient Support Programme Abbvie C..:

Martinez-Sesmero, JM ; Burgos-Pol, R ; Jornet, S...
Value in Health. 20 (2017) 9 - p. A554 , 2017

Link: https://doi.org/10.1016/..

4

Cost Per Responder of Apremilast Versus Infliximab Biosimil..:

Martinez-Sesmero, JM ; Schoendorff, C ; Caloto, T
Value in Health. 19 (2016) 7 - p. A569 , 2016

Link: https://doi.org/10.1016/..

5

Cost-Utility Analysis of Dolutegravir/Abacavir/Lamivudine (..:

Parrondo, J ; Moreno, S ; Losa, JE...
Value in Health. 18 (2015) 7 - p. A588-A589 , 2015

Link: https://doi.org/10.1016/..

6

Patient Experience Evaluation of the CMO-Based Pharmaceutic..:

Morillo-Verdugo R ; Lazaro-Lopez A ; Alonso-Grandes E...
https://www.dovepress.com/patient-experience-evaluation-of-the-cmo-based-pharmaceutical-care-mod-peer-reviewed-fulltext-article-JMDH. , 2022

Link: https://doaj.org/article..

7

Hacia una Farmacia Hospitalaria Digital:

Montero Delgado, JA ; Monte Boquet, E ; Martínez Sesmero, JM
Revista de la OFIL. 30 (2020) 1 - p. 12-13 , 2020

Link: https://doi.org/10.4321/..

8

Burden of diabetes mellitus in patients with acromegaly tre..:

Sánchez-Cenizo L ; Aller J ; Martínez-Sesmero JM...
https://www.dovepress.com/burden-of-diabetes-mellitus-in-patients-with-acromegaly-treated-with-s-peer-reviewed-article-CEOR. , 2019

Link: https://doaj.org/article..

9

Burden of diabetes mellitus in patients with acromegaly tre..:

Sánchez-Cenizo, L ; Aller, J ; Martínez-Sesmero, JM...
info:eu-repo/semantics/altIdentifier/doi/10.2147/CEOR.S204276. , 2019

Link: https://www.dovepress.co..

10

4CPS-088 Direct-acting antivirals for the treatment of hepa..:

Sacristan, A Garcia ; Martínez-Sesmero, JM ; Ambel, H Quirós...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7535248/. , 2018

Link: http://www.ncbi.nlm.nih...

11

INT-011 Prevalence and pharmacotherapeutic complexity of po..:

Morillo-Verdugo, R ; Robustillo-Cortes, MA ; Sanchez-Rubio, J..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7535411/. , 2018

Link: http://www.ncbi.nlm.nih...

12

How Do Hospital Pharmacists Approach Substitution of Nanome..:

Sofia, N ; Mühlebach, S ; Musazzi, UM...
https://eprints.whiterose.ac.uk/175876/1/pharmaceutics-13-01010%20%281%29.pdf. , 2021

Link: https://eprints.whiteros..

13

5PSQ-076 Patient-reported outcomes in multiple sclerosis:

Sacristan, A Garcia ; Sánchez, P López ; Sesmero, JM Martínez...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7535601/. , 2018

Link: http://www.ncbi.nlm.nih...

14

4CPS-034 Effectiveness and safety of monoclonal antibodies ..:

Ambel, H Quiros ; Rengifo, C Donoso ; Sacristán, AA García...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7535333/. , 2018

Link: http://www.ncbi.nlm.nih...

15

6ER-014 Patient-reported outcomes regarding adalimumab new ..:

Sánchez, P López ; Sacristán, A García ; Morago, R Martínez...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7535496/. , 2018

Link: http://www.ncbi.nlm.nih...